TR201904587A2 - Sembleferon halka seti̇ - Google Patents

Sembleferon halka seti̇ Download PDF

Info

Publication number
TR201904587A2
TR201904587A2 TR2019/04587A TR201904587A TR201904587A2 TR 201904587 A2 TR201904587 A2 TR 201904587A2 TR 2019/04587 A TR2019/04587 A TR 2019/04587A TR 201904587 A TR201904587 A TR 201904587A TR 201904587 A2 TR201904587 A2 TR 201904587A2
Authority
TR
Turkey
Prior art keywords
sembleferon
ring set
symblepharon
suture
ring
Prior art date
Application number
TR2019/04587A
Other languages
English (en)
Inventor
Atakan Özcan Altan
Original Assignee
Cukurova Ueniversitesi Rektoerluegue
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cukurova Ueniversitesi Rektoerluegue filed Critical Cukurova Ueniversitesi Rektoerluegue
Priority to TR2019/04587A priority Critical patent/TR201904587A2/tr
Publication of TR201904587A2 publication Critical patent/TR201904587A2/tr
Priority to PCT/TR2019/050974 priority patent/WO2020197517A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/005—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/048—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/147—Implants to be inserted in the stroma for refractive correction, e.g. ring-like implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Prostheses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Buluş, semblefaron ile seyreden göz hastalıkları ve kornea yaraları için herhangi bir sütür (dikiş) uygulaması gerekmeden özellikle tek bir işlem ile ileri yaşta ve genel anestezi alamayacak hastalar için geliştirilmiş semblefaron halkası - doku özel bir kilit sistemi ile ilgilidir.
TR2019/04587A 2019-03-27 2019-03-27 Sembleferon halka seti̇ TR201904587A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2019/04587A TR201904587A2 (tr) 2019-03-27 2019-03-27 Sembleferon halka seti̇
PCT/TR2019/050974 WO2020197517A1 (en) 2019-03-27 2019-11-19 A symblepharon ring set

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2019/04587A TR201904587A2 (tr) 2019-03-27 2019-03-27 Sembleferon halka seti̇

Publications (1)

Publication Number Publication Date
TR201904587A2 true TR201904587A2 (tr) 2019-04-22

Family

ID=67980707

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/04587A TR201904587A2 (tr) 2019-03-27 2019-03-27 Sembleferon halka seti̇

Country Status (2)

Country Link
TR (1) TR201904587A2 (tr)
WO (1) WO2020197517A1 (tr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020236125A3 (en) * 2019-05-02 2021-01-14 Ondokuz Mayis Universitesi An amniotic membrane transplantation system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI290055B (en) * 2002-03-14 2007-11-21 Tissuetech Inc Amniotic membrane covering for a tissue surface and devices facilitating fastening of membranes
CN103705337B (zh) * 2012-10-09 2015-07-29 王青 眼表羊膜覆盖器
CN203280570U (zh) * 2013-05-21 2013-11-13 中南大学 可调性结膜囊分离环

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020236125A3 (en) * 2019-05-02 2021-01-14 Ondokuz Mayis Universitesi An amniotic membrane transplantation system

Also Published As

Publication number Publication date
WO2020197517A1 (en) 2020-10-01

Similar Documents

Publication Publication Date Title
ECSP23057029A (es) Agonistas del receptor gpcr, composiciones farmacéuticas que los comprenden y métodos para su uso
CY1120950T1 (el) Θεραπεια ινωσης
CL2017001920A1 (es) Anticuerpos humanos contra glicoproteína del virus ébola
MX2019011148A (es) Metodos de tratamiento.
EA201792642A1 (ru) Способы диагностики для т-клеточной терапии
BR112018073574A2 (pt) conjugados de anticorpo-fármaco anti-cmet e métodos para a sua utilização
PE20180131A1 (es) Terapia de combinacion del receptor del factor de crecimiento de fibroblastos (fgfr)/muerte programada 1 (pd 1) para el tratamiento del cancer
UY35416A (es) Anticuerpos humanos de la proteína f del virus respiratorio sincicial y métodos de uso de estos.
CL2018000750A1 (es) Método de redireccionamiento de linfocitos t para el tratamiento de la infección por vih
BR112019001923A2 (pt) moduladores de nmda de espiro-lactama e métodos de sua utilização
BR112018075300A2 (pt) métodos para tratamento do mal de alzheimer
CY1122072T1 (el) Μη-ανταγωνιστικα αντισωματα κατευθυνομενα εναντι της αλφα αλυσου του εξωκυτταρικου πεδιου υποδοχεα il7 και χρηση αυτων σε θεραπεια καρκινου
CL2020001131A1 (es) Administración oral de análogos del péptido glp-1.
CO2021009693A2 (es) Proteínas de unión a antígeno del receptor gamma anti-il2
BR112015010039A2 (pt) tratamento de câncer com pomalidomida em um individuo com disfunção renal
AU2019310335A8 (en) Methods of treating cancer with PI3K inhibitor, GDC-0077
BR112022010419A2 (pt) Tratamento de hipoparatireoidismo
MX2021002380A (es) Conjugados de isoquinolina-esteroide y usos de los mismos.
TR201904587A2 (tr) Sembleferon halka seti̇
CO2021005207A2 (es) Métodos de tratamiento
BR112022007721A2 (pt) Método para o tratamento da demência
CL2017000378A1 (es) Métodos para tratar la depresión usando moduladores de nmda
MX2021014905A (es) Células seguras e invisibles para el sistema inmunitario.
MX2018002298A (es) Metodos de uso de interleucina 10 para el tratamiento de enfermedades y trastornos.
EA201891419A1 (ru) Пептид-олигонуклеотидные конъюгаты